Terns Pharmaceuticals, Inc.

DB:430 Stock Report

Market Cap: €4.6b

Terns Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:430 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Jan 26Sell€6,743Emil KuriakoseIndividual200€33.72
02 Jan 26Sell€31,189Emil KuriakoseIndividual955€32.66
01 Oct 25Sell€6,314Emil KuriakoseIndividual944€6.69
01 Jul 25Sell€3,092Emil KuriakoseIndividual853€3.62
27 Jun 25Buy€33,528Andrew GengosIndividual10,000€3.35
25 Jun 25Buy€77,607Amy BurroughsIndividual23,314€3.33
16 Jun 25Buy€49,256Andrew GengosIndividual15,000€3.41
01 Apr 25Sell€2,189Emil KuriakoseIndividual952€2.30

Insider Trading Volume

Insider Buying: 430 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of 430?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders316,9500.26%
Hedge Funds5,550,0004.55%
Institutions116,074,41595.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.6%.


Top Shareholders

Top 25 shareholders own 72.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.53%
BlackRock, Inc.
8,193,935€343.4m47.6%0.01%
7.23%
Morgan Stanley
7,868,431€329.7m4.31%0.04%
5.1%
Adage Capital Management, L.P.
5,550,000€232.6m40.9%0.42%
5.08%
The Vanguard Group, Inc.
5,523,948€231.5m21.1%no data
4.14%
Vestal Point Capital, LP
4,500,000€188.6m0%7.55%
4%
Avoro Capital Advisors LLC
4,350,000€182.3m0%2.25%
3.72%
Vivo Capital, LLC
4,042,143€169.4m-24.4%11.4%
3.11%
Janus Henderson Group plc
3,379,569€141.6m0%0.06%
2.91%
Citadel Advisors LLC
3,166,642€132.7m99.2%0.11%
2.8%
Capitolis Advisors LLC
3,045,200€127.6m0%0.94%
2.55%
Holocene Advisors, LP
2,775,493€116.3m0%0.3%
2.5%
Franklin Resources, Inc.
2,715,034€113.8m113%0.04%
2.49%
Lord, Abbett & Co. LLC
2,712,399€113.7m19,300%0.4%
1.98%
OrbiMed Advisors LLC
2,153,300€90.2m-71.5%1.57%
1.93%
Geode Capital Management, LLC
2,096,642€87.9m22.3%0.01%
1.74%
Columbia Management Investment Advisers, LLC
1,894,381€79.4m0%0.02%
1.63%
State Street Global Advisors, Inc.
1,775,922€74.4m10.6%no data
1.61%
Acorn Bioventures
1,746,264€73.2m-11.4%26.5%
1.57%
Nearwater Capital Markets, Limited
1,704,800€71.4m0%1.41%
1.47%
Ikarian Capital, LLC
1,596,378€66.9m872%11.4%
1.45%
Pictet Asset Management Limited
1,577,116€66.1m42.8%0.06%
1.44%
JP Morgan Asset Management
1,571,025€65.8m162%0.01%
1.39%
Healthcare of Ontario Pension Plan Trust Fund
1,515,400€63.5m0%0.12%
1.36%
Commodore Capital LP
1,475,000€61.8m-74.1%3.93%
1.29%
The Toronto-Dominion Bank
1,400,802€58.7m0%0.08%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/22 17:54
End of Day Share Price 2026/03/20 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Terns Pharmaceuticals, Inc. is covered by 19 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBarclays
Etzer DaroutBMO Capital Markets Equity Research
Evan SeigermanBMO Capital Markets Equity Research